novo nordisk glp-1 medications launches Wegovy weight-loss pill in US, triggering price war | Pharmaceuticals industry Novo Nordisk justifies reasoning behind
Description
10.1016/s0140-6736(23)01163-7
ChenTTianPHuangZZhaoXWangHXiaCet al
The program, currently available in 28 states, is intended for eligible overweight and obese adults ages 18-64 who plan to self-pay for their GLP-1 medication
You dont have to figure this out alone
As such, I strongly counsel my patients to eat plenty of high-quality protein, like chicken, fish, and shellfish, or soy, beans, and legumes if theyre vegetarian, to ensure they experience as little muscle wasting as possible
